NVNO.US enVVeno Medical Corp

Healthcare Health Care Equipment & Supplies USA Stocks
6.17 USD
Close of Nov 15, 2026
5.80 14.67
Market cap
USD 4.29M
P/E
-
P/B
0.21x
ROE
-93.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NVNO.US undervalued?

Graham number

The Graham number of enVVeno Medical Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

enVVeno Medical Corp fundamental analysis

No fundamental analysis for enVVeno Medical Corp yet.

enVVeno Medical Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About enVVeno Medical Corp

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the uppe…

Full company profile